A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.

<h4>Background</h4>Innovations for undernourished pregnant women that improve newborn survival and anthropometry are needed to achieve the Sustainable Development Goals 1 and 3. This study tested the hypothesis that a combination of a nutritious supplementary food and several proven chem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David Taylor Hendrixson, Kristie Smith, Patrick Lasowski, Meghan Callaghan-Gillespie, Jacklyn Weber, Peggy Papathakis, Per Ole Iversen, Aminata Shamit Koroma, Mark J Manary
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Acceso en línea:https://doaj.org/article/d3f5d38fd6dc4ff9a84722027ff8b46c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d3f5d38fd6dc4ff9a84722027ff8b46c
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
David Taylor Hendrixson
Kristie Smith
Patrick Lasowski
Meghan Callaghan-Gillespie
Jacklyn Weber
Peggy Papathakis
Per Ole Iversen
Aminata Shamit Koroma
Mark J Manary
A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
description <h4>Background</h4>Innovations for undernourished pregnant women that improve newborn survival and anthropometry are needed to achieve the Sustainable Development Goals 1 and 3. This study tested the hypothesis that a combination of a nutritious supplementary food and several proven chemotherapeutic interventions to control common infections would increase newborn weight and length in undernourished pregnant women.<h4>Methods and findings</h4>This was a prospective, randomized, controlled clinical effectiveness trial of a ready-to-use supplementary food (RUSF) plus anti-infective therapies compared to standard therapy in undernourished pregnant women in rural Sierra Leone. Women with a mid-upper arm circumference (MUAC) ≤23.0 cm presenting for antenatal care at one of 43 government health clinics in Western Rural Area and Pujehun districts were eligible for participation. Standard of care included a blended corn/soy flour and intermittent preventive treatment for malaria in pregnancy (IPTp). The intervention replaced the blended flour with RUSF and added azithromycin and testing and treatment for vaginal dysbiosis. Since the study involved different foods and testing procedures for the intervention and control groups, no one except the authors conducting the data analyses were blinded. The primary outcome was birth length. Secondary outcomes included maternal weight gain, birth weight, and neonatal survival. Follow-up continued until 6 months postpartum. Modified intention to treat analyses was undertaken. Participants were enrolled and followed up from February 2017 until February 2020. Of the 1,489 women enrolled, 752 were allocated to the intervention and 737 to the standard of care. The median age of these women was 19.5 years, of which 42% were primigravid. Twenty-nine women receiving the intervention and 42 women receiving the standard of care were lost to follow-up before pregnancy outcomes were obtained. There were 687 singleton live births in the intervention group and 657 in the standard of care group. Newborns receiving the intervention were 0.3 cm longer (95% confidence interval (CI) 0.09 to 0.6; p = 0.007) and weighed 70 g more (95% CI 20 to 120; p = 0.005) than those receiving the standard of care. Those women receiving the intervention had greater weekly weight gain (mean difference 40 g; 95% CI 9.70 to 71.0, p = 0.010) than those receiving the standard of care. There were fewer neonatal deaths in the intervention (n = 13; 1.9%) than in the standard of care (n = 28; 4.3%) group (difference 2.4%; 95% CI 0.3 to 4.4), (HR 0.62 95% CI 0.41 to 0.94, p = 0.026). No differences in adverse events or symptoms between the groups was found, and no serious adverse events occurred. Key limitations of the study are lack of gestational age estimates and unblinded administration of the intervention.<h4>Conclusions</h4>In this study, we observed that the addition of RUSF, azithromycin, more frequent IPTp, and testing/treatment for vaginal dysbiosis in undernourished pregnant women resulted in modest improvements in anthropometric status of mother and child at birth, and a reduction in neonatal death. Implementation of this combined intervention in rural, equatorial Africa may well be an important, practical measure to reduce infant mortality in this context.<h4>Trial registration</h4>ClinicalTrials.gov NCT03079388.
format article
author David Taylor Hendrixson
Kristie Smith
Patrick Lasowski
Meghan Callaghan-Gillespie
Jacklyn Weber
Peggy Papathakis
Per Ole Iversen
Aminata Shamit Koroma
Mark J Manary
author_facet David Taylor Hendrixson
Kristie Smith
Patrick Lasowski
Meghan Callaghan-Gillespie
Jacklyn Weber
Peggy Papathakis
Per Ole Iversen
Aminata Shamit Koroma
Mark J Manary
author_sort David Taylor Hendrixson
title A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
title_short A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
title_full A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
title_fullStr A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
title_full_unstemmed A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
title_sort novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in sierra leone: a randomized, controlled clinical effectiveness trial.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d3f5d38fd6dc4ff9a84722027ff8b46c
work_keys_str_mv AT davidtaylorhendrixson anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT kristiesmith anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT patricklasowski anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT meghancallaghangillespie anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT jacklynweber anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT peggypapathakis anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT peroleiversen anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT aminatashamitkoroma anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT markjmanary anovelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT davidtaylorhendrixson novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT kristiesmith novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT patricklasowski novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT meghancallaghangillespie novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT jacklynweber novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT peggypapathakis novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT peroleiversen novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT aminatashamitkoroma novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
AT markjmanary novelinterventioncombiningsupplementaryfoodandinfectioncontrolmeasurestoimprovebirthoutcomesinundernourishedpregnantwomeninsierraleonearandomizedcontrolledclinicaleffectivenesstrial
_version_ 1718375870580654080
spelling oai:doaj.org-article:d3f5d38fd6dc4ff9a84722027ff8b46c2021-12-02T19:55:46ZA novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.1549-12771549-167610.1371/journal.pmed.1003618https://doaj.org/article/d3f5d38fd6dc4ff9a84722027ff8b46c2021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.pmed.1003618https://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Innovations for undernourished pregnant women that improve newborn survival and anthropometry are needed to achieve the Sustainable Development Goals 1 and 3. This study tested the hypothesis that a combination of a nutritious supplementary food and several proven chemotherapeutic interventions to control common infections would increase newborn weight and length in undernourished pregnant women.<h4>Methods and findings</h4>This was a prospective, randomized, controlled clinical effectiveness trial of a ready-to-use supplementary food (RUSF) plus anti-infective therapies compared to standard therapy in undernourished pregnant women in rural Sierra Leone. Women with a mid-upper arm circumference (MUAC) ≤23.0 cm presenting for antenatal care at one of 43 government health clinics in Western Rural Area and Pujehun districts were eligible for participation. Standard of care included a blended corn/soy flour and intermittent preventive treatment for malaria in pregnancy (IPTp). The intervention replaced the blended flour with RUSF and added azithromycin and testing and treatment for vaginal dysbiosis. Since the study involved different foods and testing procedures for the intervention and control groups, no one except the authors conducting the data analyses were blinded. The primary outcome was birth length. Secondary outcomes included maternal weight gain, birth weight, and neonatal survival. Follow-up continued until 6 months postpartum. Modified intention to treat analyses was undertaken. Participants were enrolled and followed up from February 2017 until February 2020. Of the 1,489 women enrolled, 752 were allocated to the intervention and 737 to the standard of care. The median age of these women was 19.5 years, of which 42% were primigravid. Twenty-nine women receiving the intervention and 42 women receiving the standard of care were lost to follow-up before pregnancy outcomes were obtained. There were 687 singleton live births in the intervention group and 657 in the standard of care group. Newborns receiving the intervention were 0.3 cm longer (95% confidence interval (CI) 0.09 to 0.6; p = 0.007) and weighed 70 g more (95% CI 20 to 120; p = 0.005) than those receiving the standard of care. Those women receiving the intervention had greater weekly weight gain (mean difference 40 g; 95% CI 9.70 to 71.0, p = 0.010) than those receiving the standard of care. There were fewer neonatal deaths in the intervention (n = 13; 1.9%) than in the standard of care (n = 28; 4.3%) group (difference 2.4%; 95% CI 0.3 to 4.4), (HR 0.62 95% CI 0.41 to 0.94, p = 0.026). No differences in adverse events or symptoms between the groups was found, and no serious adverse events occurred. Key limitations of the study are lack of gestational age estimates and unblinded administration of the intervention.<h4>Conclusions</h4>In this study, we observed that the addition of RUSF, azithromycin, more frequent IPTp, and testing/treatment for vaginal dysbiosis in undernourished pregnant women resulted in modest improvements in anthropometric status of mother and child at birth, and a reduction in neonatal death. Implementation of this combined intervention in rural, equatorial Africa may well be an important, practical measure to reduce infant mortality in this context.<h4>Trial registration</h4>ClinicalTrials.gov NCT03079388.David Taylor HendrixsonKristie SmithPatrick LasowskiMeghan Callaghan-GillespieJacklyn WeberPeggy PapathakisPer Ole IversenAminata Shamit KoromaMark J ManaryPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 18, Iss 9, p e1003618 (2021)